Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

Inclusion Criteria:

To be included in the study, you must meet the following criteria:

18 years of age or older
Non-small cell lung cancer confirmed by biopsy
Unresectable stage III or IV disease
Measurable disease
Must not have received any prior chemotherapy for lung cancer
Able to perform activities of daily living without considerable assistance
Adequate bone marrow, kidney, and liver function
Signed informed consent

Exclusion Criteria:

You cannot participate in the study if any of the following apply to you:

History of serious heart disease within six months prior to study entry
Prior treatment with agents that target the EGFR pathway
History of any other uncontrolled or significant disease

Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have. You can then decide if you wish to participate.